Baxter International (BAX) Other financing activities (2009 - 2026)
Baxter International's (BAX) quarterly Other financing activities came in at -$14.0 million in Q1 2026, up 41.67% year-on-year from -$9.9 million in Q1 2025, and up 64.1% on a QoQ basis from -$39.0 million in Q4 2025.
Baxter International (BAX) Other financing activities (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of Other financing activities data on file, last reported at -$14.0 million in Q1 2026.
- On a quarterly basis, Other financing activities rose 41.67% year-over-year to -$14.0 million in Q1 2026; TTM through Mar 2026 was -$47.0 million, a 771.43% decrease from a year earlier, with the FY2025 full-year figure at -$57.0 million, down 180.28% from the prior year.
- Other financing activities for Q1 2026 stood at -$14.0 million, up from -$39.0 million in the prior quarter.
- Over the last five years, Other financing activities for BAX reached as high as $72.0 million in Q3 2024 and fell as low as -$116.0 million in Q3 2023.
- Historically, Other financing activities has averaged -$7.3 million across 5 years, with a median of -$10.0 million in 2022.
- Across the five-year window, Other financing activities sank 625.0% in 2022 and jumped 1380.0% in 2023, its largest moves.
- Year by year, Other financing activities stood at -$10.0 million in 2022, then soared by 90.0% to -$1.0 million in 2023, then jumped by 900.0% to $8.0 million in 2024, then tumbled by 587.5% to -$39.0 million in 2025, then jumped by 64.1% to -$14.0 million in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were -$14.0 million in Q1 2026, -$39.0 million in Q4 2025, and $7.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.00 Mn |
| Mar 31, 2026 | -14.00 Mn |
| Dec 31, 2025 | -39.00 Mn |
| Dec 31, 2025 | -39.00 Mn |
| Sep 30, 2025 | 7.00 Mn |
| Sep 30, 2025 | 7.00 Mn |
| Jun 30, 2025 | -1.00 Mn |
| Jun 30, 2025 | -1.00 Mn |
| Mar 31, 2025 | -24.00 Mn |
| Mar 31, 2025 | -24.00 Mn |
| Dec 31, 2024 | 8.00 Mn |
| Dec 31, 2024 | 8.00 Mn |
| Sep 30, 2024 | 72.00 Mn |
| Sep 30, 2024 | 72.00 Mn |
| Jun 30, 2024 | -49.00 Mn |
| Jun 30, 2024 | -49.00 Mn |
| Mar 31, 2024 | 40.00 Mn |
| Mar 31, 2024 | 40.00 Mn |
| Dec 31, 2023 | -1.00 Mn |
| Dec 31, 2023 | -1.00 Mn |